
EquitySector - HealthcareVery High Risk
Regular
NAV (13-Nov-26)
Returns (Since Inception)
Fund Size
₹419 Cr
Expense Ratio
2.59%
ISIN
INF0QA701987
Minimum SIP
₹500
Exit Load
1.00%
Inception Date
27 Dec 2024
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
+22.04%
+20.21% (Cat Avg.)
Since Inception
+10.69%
— (Cat Avg.)
| Equity | ₹399.63 Cr | 95.42% |
| Debt | ₹0.88 Cr | 0.21% |
| Others | ₹18.31 Cr | 4.37% |
All Holdings
Equity
Debt & Others
| Name | Type | Amount | Holdings |
|---|---|---|---|
| Divi's Laboratories Ltd | Equity | ₹36.71 Cr | 8.76% |
| Sun Pharmaceuticals Industries Ltd | Equity | ₹35.52 Cr | 8.48% |
| Piramal Pharma Ltd | Equity | ₹29.79 Cr | 7.11% |
| Apollo Hospitals Enterprise Ltd | Equity | ₹26.98 Cr | 6.44% |
| Aurobindo Pharma Ltd | Equity | ₹24.57 Cr | 5.87% |
| Rubicon Research Ltd | Equity | ₹24.48 Cr | 5.84% |
| Laurus Labs Ltd | Equity | ₹19.24 Cr | 4.59% |
| Torrent Pharmaceuticals Ltd | Equity | ₹18.61 Cr | 4.44% |
| Dr Reddy's Laboratories Ltd | Equity | ₹16.61 Cr | 3.96% |
| Emcure Pharmaceuticals Ltd | Equity | ₹15.73 Cr | 3.76% |
| Neuland Laboratories Ltd | Equity | ₹14.27 Cr | 3.41% |
| Zydus Lifesciences Ltd | Equity | ₹12.28 Cr | 2.93% |
| Alkem Laboratories Ltd | Equity | ₹11.88 Cr | 2.84% |
| Max Healthcare Institute Ltd Ordinary Shares | Equity | ₹11.21 Cr | 2.68% |
| Ipca Laboratories Ltd | Equity | ₹9.73 Cr | 2.32% |
| Fortis Healthcare Ltd | Equity | ₹9.23 Cr | 2.20% |
| Vijaya Diagnostic Centre Ltd | Equity | ₹8.92 Cr | 2.13% |
| Net Receivables / (Payables) | Cash | ₹8.61 Cr | 2.06% |
| Zydus Wellness Ltd | Equity | ₹8.03 Cr | 1.92% |
| Shaily Engineering Plastics Ltd | Equity | ₹7.86 Cr | 1.88% |
| Senores Pharmaceuticals Ltd | Equity | ₹6.91 Cr | 1.65% |
| Dr. Lal PathLabs Ltd | Equity | ₹6.72 Cr | 1.60% |
| Glenmark Pharmaceuticals Ltd | Equity | ₹6.38 Cr | 1.52% |
| GlaxoSmithKline Pharmaceuticals Ltd | Equity | ₹5.93 Cr | 1.42% |
| Cipla Ltd | Equity | ₹5.52 Cr | 1.32% |
| Bajaj Money Market Dir Gr | Mutual Fund - Open End | ₹5.33 Cr | 1.27% |
| Clearing Corporation Of India Ltd | Cash - Repurchase Agreement | ₹5.26 Cr | 1.26% |
| Sanofi Consumer Healthcare India Ltd | Equity | ₹4.77 Cr | 1.14% |
| Biocon Ltd | Equity | ₹4.03 Cr | 0.96% |
| Navin Fluorine International Ltd | Equity | ₹4 Cr | 0.96% |
| Krishna Institute of Medical Sciences Ltd | Equity | ₹3.51 Cr | 0.84% |
| OneSource Specialty Pharma Ltd | Equity | ₹3.44 Cr | 0.82% |
| Jubilant Pharmova Ltd | Equity | ₹3.23 Cr | 0.77% |
| Medi Assist Healthcare Services Ltd | Equity | ₹1.97 Cr | 0.47% |
| Neogen Chemicals Ltd | Equity | ₹0.84 Cr | 0.20% |
| Sumitomo Chemical India Ltd Ordinary Shares | Equity | ₹0.63 Cr | 0.15% |
| Nifty 22500 Put November 2026 Option | Equity Index - Option (Put) | ₹0.09 Cr | 0.02% |
Large Cap Stocks
29.45%
Mid Cap Stocks
31.30%
Small Cap Stocks
34.65%
AAA
Equity Sector
Debt & Others
| Sector | Amount | Holdings |
|---|---|---|
| Healthcare | ₹378.17 Cr | 90.29% |
| Basic Materials | ₹13.33 Cr | 3.18% |
| Consumer Defensive | ₹8.03 Cr | 1.92% |
Standard Deviation
This fund
--
Cat. avg.
16.11%
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
0.94
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
1.63
Higher the better
ISIN INF0QA701987 | Expense Ratio 2.59% | Exit Load 1.00% | Fund Size ₹419 Cr | Age 1 year 10 months | Lumpsum Minimum ₹500 | Fund Status Open Ended Investment Company | Benchmark BSE Healthcare TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Total AUM
₹38,002 Cr
Address
8th floor, E-Core,Solitaire Business Hub (formerly Marvel Edge), Viman Nagar 411014
Your principal amount will be at Very High Risk

Download Dezerv App
Track and monitor all
your investments